The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression
Open accessPublished version of a preprint
Abstract
Age is a major risk factor for the development of cancer. Senescent fibroblasts, which accumulate with age, secrete protumorigenic factors collectively referred to as the senescence-associated secretory phenotype (SASP). Here, we examined the molecular mechanisms that control SASP activation, focusing on the known SASP factor osteopontin (OPN). We found that expression of the canonical SASP members interleukin (IL)-6 and IL-8, but not OPN, were dependent upon a persistent DNA damage response (DDR) as evidenced by ATM and NF-κB activation. Treatment with several histone deacetylase (HDAC) inhibitors robustly activated SASP in the absence of DNA breaks, suggesting that DDR-dependent SASP activation occurs in response to chromatin remodeling rather than physical breaks in DNA. In the setting of HDAC inhibition, IL-6 and IL-8 expression remained dependent upon ATM and NF-κB, while OPN expression remained independent of these factors. Further analysis revealed that HDAC1 inhibition was sufficient to induce OPN expression, which is interesting given that loss of HDAC1 expression correlates with increased OPN expression within the stromal compartment of invasive breast cancers. Importantly, fibroblasts treated with HDAC inhibitors promoted tumor growth in vivo. Our findings therefore indicate that HDAC modulation plays an important role in stromal cell activation, with important implications for the use of HDAC inhibitors in the treatment of cancer. Cancer Res; 72(9); 2251–61. ©2012 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SASP is primarily a property of cells that senesce owing to, or accompanied by, genomic damage or epigenomic perturbation.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, cells that senesce owing to DNA damage, dysfunctional telomeres, epigenomic disruption, mitogenic signals, oxidative stress, and other senescence-inducing stimuli develop a SASP of varying qualities and robustness (32, 33, 42, 67, 94, 96, 99, 100, 112–114).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The SASP is also positively regulated by the transcription factors nuclear factor κB (NF-κB) (57, 67, 99) and C/EBP-β (100) (Figure 2).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both AP-1 and NFKB1 are implicated in establishing senescence and regulating the SASP.43,44”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [44]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Many, but not all, SASP components are positively regulated by the DDR proteins ATM, NBS1 (Nijmegen breakage syndrome 1), and CHK2 (checkpoint kinase 2) (42, 67).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [67]
The cited source says what the claim attributes to it.
In the citing paper
“at millimolar doses, TSA has been shown to promote senescence and development of the SASP (Pazolli et al. 2012)”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Pazolli et al. 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A simple technique for quantitation of low levels of DNA damage in individual cells
Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Rhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 6×
“In efforts to understand how this is accomplished, several groups have examined the expression profile of senescent cells and uncovered a signature secretory program enriched in growth factors, cytokines, and proteases termed the SASP (4, 5, 15, 16).”
Influential
Cited by
Sorted by citations
Items 101–192 of 192
HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts
Warnon, C., Bouhjar, K., Ninane, N., Verhoyen, M., Fattaccioli, A., Fransolet, M., Lambert de Rouvroit, C., Poumay, Y., Piel, G., Mottet, D., et al. (2021) · Aging · doi:10.18632/aging.203304 · Cited by 25
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
Awakening of Dormant Breast Cancer Cells in the Bone Marrow
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15113021 · Cited by 26
Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer
He, Y., Qiu, Y., Yang, X., Lu, G., & Zhao, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.002 · Cited by 25
Non‐canonical ATM/MRN activities temporally define the senescence secretory program
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G., Campisi, J., & Rodier, F. (2020) · EMBO Reports · doi:10.15252/embr.202050718 · Cited by 25
Mechanisms of Senescence and Anti-Senescence Strategies in the Skin
Konstantinou, E. K., Longange, E., & Kaya, G. (2024) · Biology · doi:10.3390/biology13090647 · Cited by 26
Basu, D., Reyes‐Múgica, M., & Rebbaa, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052188 · Cited by 26
Marsh, T., Wong, I. G., Sceneay, J., Barakat, A., Qin, Y., Sjödin, A., Alspach, E., Nilsson, B., Stewart, S. A., & McAllister, S. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3332 · Cited by 24
Self-citationOta, D., Kanayama, M., Matsui, Y., Ito, K., Maeda, N., Kutomi, G., Hirata, K., Torigoe, T., Sato, N., Takaoka, A., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1183-9 · Cited by 26
Guo, Y., Chomiak, A. A., Hong, Y., Lowe, C. C., Kopsidas, C. A., Chan, W., Andrade, J., Pan, H., Zhou, X., Monuki, E. S., et al. (2021) · iScience · doi:10.1016/j.isci.2022.104519 · Cited by 24
Mechanisms and markers of malignant transformation of oral submucous fibrosis
Fen, L., Xiao, T., Wang, B., Wang, L., Liu, G., Wang, R., Xie, C., & Tang, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23314 · Cited by 23
Pietrogrande, G., Shaker, M. R., Stednitz, S. J., Soheilmoghaddam, M., Aguado, J., Morrison, S. D., Zambrano, S., Tabassum, T., Javed, I., Cooper-White, J. J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02732-0 · Cited by 23
Liu, K., Li, Y., Shen, M., Xu, W., Wu, S., Yang, X., Zhang, B., & Lin, N. (2025) · Biomolecules · doi:10.3390/biom15010071 · Cited by 23
Liu, L., Wan, W., Chang, Y., Ao, L., Xu, Y., & Xu, X. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03527-z · Cited by 27
Where does cellular senescence belong in the pathophysiology of ovarian cancer?
Książek, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.021 · Cited by 22
Dynamic Aging: Channeled Through Microenvironment
Tan, Q., Liang, N., Zhang, X., & Li, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.702276 · Cited by 25
Balamurli, G., Liew, A. Q. X., Tee, W., & Pervaiz, S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103441 · Cited by 23
Ren, F., Meng, L., Zheng, S., Cui, J., Song, S., Li, X., Wang, D., Li, X., Liu, Q., Bu, W., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03290-1 · Cited by 21
Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 19
Huff, L. A., Yan, S., & Clemens, M. G. (2021) · Antioxidants · doi:10.3390/antiox10071146 · Cited by 21
Sharma, R. L., Mishra, A., Bhardwaj, M., Singh, G., Harahap, L. V. I., Vanjani, S., Pan, C., & Nepali, K. (2025) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2489720 · Cited by 20
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Morgan, M. P., Finnegan, E., & Das, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.002 · Cited by 19
Cellular senescence and ophthalmic diseases: narrative review
Soleimani, M., Cheraqpour, K., Koganti, R., & Djalilian, A. R. (2023) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-023-06070-9 · Cited by 18
Histone Acetylation-Mediated Regulation of the Hippo Pathway
Basu, D., Reyes‐Múgica, M., & Rebbaa, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062478 · Cited by 20
Mizutani, T., Ishizaka, A., & Furuichi, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657155 · Cited by 17
Therapeutic agents for targeting desmoplasia: current status and emerging trends
Nandi, T., Pradyuth, S. K., Singh, A. K., Chitkara, D., & Mittal, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.008 · Cited by 19
Sylvestre, M., Tarte, K., & Roulois, D. (2019) · Epigenomics · doi:10.2217/epi-2019-0165 · Cited by 18
Na, H. Y., Park, J. H., Shin, S. A., Lee, S., Lee, H., Chae, H., Choung, H.-K., Kim, N., Chung, J.-H., & Kim, J. E. (2021) · Cancers · doi:10.3390/cancers13194810 · Cited by 16
Cai, X., Zhang, H., & Li, T. (2021) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2021.07.022 · Cited by 15
Rutecki, S., Pakuła‐Iwańska, M., Leśniewska-Bocianowska, A., Matuszewska, J., Rychlewski, D., Uruski, P., Stryczyński, Ł., Naumowicz, E., Szubert, S., Tykarski, A., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6223 · Cited by 14
Cellular senescence in human liver under normal aging and cancer
Karpova, A., Li, X., Peng, C.-W., Gallant, K. L., Rapp, D. R., Alligood, D. M., Houston, A. J., Park, A., Targino da Costa, A. L. N., Chou, W.-H., et al. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101133 · Cited by 13
Self-citationFang, X., Huang, E., Xie, X., Yang, K., Wang, S., Huang, X., & Song, M. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.951311 · Cited by 12
Shi, H., Xiao, M., Li, Y., Liu, X., Na, J., Liang, C., Hua, J., Meng, Q., Wei, M., Wang, W., et al. (2025) · Theranostics · doi:10.7150/thno.112633 · Cited by 12
Brito, S., Heo, H., Kim, J., Cha, B., Jeong, Y., Choi, W., Shrestha, C., Lee, G. H., Park, S. J., Yoon, K. B., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2024.12.024 · Cited by 12
Cellular Senescence-Inducing Small Molecules for Cancer Treatment
Liu, P., Lu, Z., Wu, Y., Shang, D., Zhao, Z., Shen, Y., Zhang, Y., Zhu, F., Liu, H., & Tu, Z. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180530092825 · Cited by 12
Bayo, J., Dalvi, M. P., & Martínez, E. D. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.140 · Cited by 12
Hom, L. M., Sun, S., Campbell, J., Liu, P., Culbert, S., Murphy, I. M., & Schafer, Z. T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104922 · Cited by 11
Jinushi, M. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9501-9 · Cited by 11
Lund, R., Emani, M., Barbaric, I., Kivinen, V., Jones, M., Baker, D., Gokhale, P. J., Nykter, M., Lahesmaa, R., & Andrews, P. W. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.07.002 · Cited by 12
Cellular senescence in cancer: Friend or fraud?
Chen, Q., Liu, J., Wu, J., Xiang, X., Zhou, X., Mi, J., Wei, J., Zou, X., & Wu, A. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101363 · Cited by 15
Procancerogenic activity of senescent cells: A case of the peritoneal mesothelium
Mikuła‐Pietrasik, J., Stryczyński, Ł., Uruski, P., Tykarski, A., & Książek, K. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.01.002 · Cited by 11
Alterations of receptors and insulin-like growth factor binding proteins in senescent cells
Matuszewska, J., Krawiec, A., Radziemski, A., Uruski, P., Tykarski, A., Mikuła‐Pietrasik, J., & Książek, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151438 · Cited by 8
Cellular senescence and senescence-associated secretory phenotype (SASP) in aging process
Olivieri, F., Procopio, A. D., & Rippo, M. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822569-1.00013-5 · Cited by 7
G-quadruplex DNA and RNA in cellular senescence
Escarcega, R. D., Marshall, P. R., & Tsvetkov, A. S. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1491389 · Cited by 9
Alghamdi, E., & Kono, K. (2025) · Cancer Science · doi:10.1111/cas.70223 · Cited by 7
Chen, P., Guo, H., Chen, J., & Fu, Y. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000304 · Cited by 6
RagC GTPase regulates mTOR to promote chemoresistance in senescence-like HepG2 cells
Jiang, W., Ou, Z., Zhu, Q., Yao, Y., & Zai, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.949737 · Cited by 5
Aziz, M. M., El‐Sheikh, M. M., Mohamed, M. A. E. H., Abdelrahman, S. S. M., & Mekkawy, M. H. (2024) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320241297342 · Cited by 6
Yoshida, G. J., Azuma, A., Miura, Y., & Orimo, A. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.2 · Cited by 5
Multiple characteristic alterations and available therapeutic strategies of cellular senescence
Zhao, Y., Li, H., Guo, Q., & Hui, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200178 · Cited by 5
Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression
Halim, C. E., Deng, S., Crasta, K., & Yap, C. T. (2025) · Cancers · doi:10.3390/cancers17081378 · Cited by 6
Hargrave, S. D., Joubert, A. M., Potter, B. V. L., Döhle, W., Marais, S., & Mercier, A. E. (2022) · Molecules · doi:10.3390/molecules27123819 · Cited by 4
Buckingham, E. M., Goldman, F. D., & Klingelhutz, A. J. (2012) · Europe PMC (PubMed Central) · Cited by 4
Starich, B., Yang, F., Tanrioven, D., Kung, H., Baek, J., Nair, P. R., Kamat, P., Macaluso, N. C., Eoh, J. H., Han, K. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.579151 · Cited by 4
Li, Y., Wei, Y., Yuan, W., Huang, Q., Zhao, Y., Zhao, W., Xu, W. D., & Wu, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6310 · Cited by 3
Cellular Senescence and Tumor Promotion
Demaria, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_79 · Cited by 3
Ramírez-Farías, C., González‐Blas, D., & Quintanar‐Stephano, A. (2021) · Revista de Senología y Patología Mamaria · doi:10.1016/j.senol.2021.08.003 · Cited by 2
Makulyte, G., Safwan‐Zaiter, H., Goehrig, D., Huna, A., Mangelinck, A., Mikawa, T., Palazzo, A., Moudombi, L., Médard, J., Chanal, M., et al. (2025) · Aging Cell · doi:10.1111/acel.70307 · Cited by 2
LI, J., Sanui, T., Shida, M., Yotsumoto, K., Ahmad, M., Wang, Z., Xiao, M., Hayashi, C., Shinjo, T., Taketomi, T., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1806138 · Cited by 2
Molecular mechanisms and recent advances in cellular senescence
Hussain, A., Tatar, M., & Gong, R. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01596-x · Cited by 2
Epiregulation of the SASP makes good neighbors
Desbats, M. A., Zumerle, S., & Alimonti, A. (2021) · Nature Aging · doi:10.1038/s43587-021-00068-w · Cited by 2
Senescence in Aging, Within the Brain and Other Diseases: Mechanisms and Interventions
Chakrabarti, S. K., & Chattopadhyay, D. (2023) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2023.00018 · Cited by 1
Cellular Senescence and Stem Cell Exhaustion: Implications for Aging and Regeneration
Kumar, N., & Walia, H. K. (2025) · Cellular Senescence, Age-Related Disorders, and Emerging Treatments · doi:10.1007/978-981-96-1041-9_6 · Cited by 1
Balancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 1
Li, W., Zhang, H., Li, S. B., Zhao, D. Y., Liang, M., Guo, Q. J., Yan, R., Shang, L., & Shi, Y. (2025) · Journal of Digestive Diseases · doi:10.1111/1751-2980.70015 · Cited by 1
Potential Applications of Aptamers for Targeting Senescent Cells
Leonardi, A., Pacifico, F., & Crescenzi, E. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_10 · Cited by 1
Breast Cancer Epigenetics: Biomarkers and Therapeutic Potential
Nabilsi, N. H., Pardo, C. E., Zajac‐Kaye, M., & Kladde, M. P. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-634-4_11 · Cited by 1
Radiation-Induced Premature Senescence of Tumor Cells
Alhaddad, L., Osipov, A. N., & Leonov, S. V. (2023) · Medical Radiology and radiation safety · doi:10.33266/1024-6177-2023-68-2-5-10 · Cited by 1
James, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1583288 · Cited by 3
Regulation and inhibition of pro-tumorigenic microenvironments
Alspach, O. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7736nxp
Impact and Challenges in Assessing Tumor Purity by Next-Generation Sequencing
Su, X., Malouf, G. G., & Esteva, F. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7645-0_18
Epigenetic Regulations of mRNAs and miRNAs by Nutraceuticals
Li, Y., Kong, D., Ahmad, A., Bao, B., & Sarkar, F. H. (2013) · Springer eBooks · doi:10.1007/978-94-007-6612-9_14
The primary cilium as a regulator of cellular senescence in human fibroblasts
Breslin, L. (2014) · ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) · doi:10.13025/17764
Nidadavolu, L. S. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
her2 hyper-activation through the production of carboxy-terminal fragments
Angelini, P. D. (2014) · TDX (Tesis Doctorals en Xarxa)
Regulation of the Pro-Tumorigenic Senescence-Associated Secretory Phenotype
Flanagan, K. C. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k75x27b7
Innate immune memory in fibroblasts
Crowley, T. E. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Cellular Senescence and Tumor Promotion
Demaria, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-44870-1_79-1
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G. B., Campisi, J., & Rodier, F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/413732
Dysregulation of synovial fibroblasts in rheumatoid arthritis
Crowley, T., Turner, J. D., Filer, A. D., Clark, A., & Buckley, C. D. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198831433.003.0006
Supporting Multiple Roles through Class Hierarchies.
Cabibbo, L. (1993)
Nicolas, A. M. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.68107
An Overview of the Role of Senescence in Cancer
Al-Janabi, I. I. (2022) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v3i.77
Pietrogrande, G., Shaker, M. R., Stednitz, S. J., Soheilmoghaddam, M., Aguado, J., Morrison, S. D., Zambrano, S., Tabassum, T., Javed, I., Cooper-White, J. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.29.555421
Xiao, H.-X., Jiang, N., Zhang, H., Wang, S., Pi, Q., Chen, H., He, X., Luo, W. F., Deng, Y., Lu, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3907908/v1
James, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F. H., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.30.609895
ATM functions as a rheostat of metabolic stress in small-cell lung cancerPreprint
Halder, D., Sen, U., Jethalia, V., Chakraborty, S., Elliott, A., Ventura, K., VanderWalde, A., Halmos, B., Borghaei, H., Thin, T. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711672
de Jong, D. (2018) · theses.fr (ABES) · doi:10.70675/27595e3bzbf8ez4196zb9b4z036b359e6b5c
An RNA Signature Links Oxidative Stress To Cellular Senescence
Mullani, N. (2019) · theses.fr (ABES) · doi:10.70675/1babf95cz77a0z4561za6cdz6bf733f9f455
CDK4/6 inhibition induces a senescence-associated secretory phenotype via delayed NF-κB activation
Yeung, J. L.-H., Rendleman, J., Westcott, L. A., Ou, A., Pressler, M., Pagane, N., Duba, I., Hosuru, R., Tumenbayar, B., & Risca, V. I. (2026) · Life Science Alliance · doi:10.26508/lsa.202603790
Zhang, J., Su, W., Duan, J., Sun, Y., & Liu, B. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100262
Metadata
- Authors
- Pazolli, E., Alspach, E., Milczarek, A., Prior, J., Piwnica-Worms, D., & Stewart, S. A.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Stewart, Sheila A.
- ORCID
- Venue
- Cancer Research
- Published
- 2012-04-30
- Volume
- 72
- Issue
- 9
- Pages
- 2251-2261
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC3605047
- OpenAlex
- W1975799119
- Cited by
- 192
- References
- 54
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 14 · 2023: 19 · 2022: 12 · 2021: 25 · 2020: 14 · 2019: 10 · 2018: 14 · 2017: 8 · 2016: 12 · 2015: 13 · 2014: 11 · 2013: 13 · 2012: 6
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (P50 CA94056, P50CA094056, R01CA130919, T32CA113275)
- National Institute of General Medical Sciences (T32GM007067)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- senescence-associated secretory phenotype, tumor stromal fibroblasts, chromatin remodeling, histone deacetylase inhibitors, HDAC1, osteopontin, interleukin-6, interleukin-8, DNA damage response, ATM, NF-κB, aging and cancer, tumor progression, breast cancer stroma, tumor growth
- MeSH terms
- Animals, Breast Neoplasms, Chromatin, DNA Damage, Female, Fibroblasts, Humans, Phenotype, RNA, Messenger, Interleukin-6, Interleukin-8, Mice, SCID, Mice, Inbred NOD, Cellular Senescence, Stromal Cells, Disease Progression, Mice, Osteopontin, Histone Deacetylase 1, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
